Célia Touraine
Célia Touraine
ICM (Montpellier Cancer Institute)
Bekræftet mail på icm.unicancer.fr
Titel
Citeret af
Citeret af
År
Interval-censored time-to-event and competing risk with death: is the illness-death model more accurate than the Cox model?
K Leffondré, C Touraine, C Helmer, P Joly
International journal of epidemiology 42 (4), 1177-1186, 2013
832013
Gait speed and decline in gait speed as predictors of incident dementia
J Dumurgier, F Artaud, C Touraine, O Rouaud, B Tavernier, C Dufouil, ...
Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2017
772017
Predictions in an illness-death model
C Touraine, C Helmer, P Joly
Statistical methods in medical research 25 (4), 1452-1470, 2016
492016
The SmoothHazard package for R: Fitting regression models to interval-censored observations of illness-death models
C Touraine, TA Gerds, P Joly
Journal of Statistical Software 79 (7), 2017
35*2017
Distribution-and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review
A Ousmen, C Touraine, N Deliu, F Cottone, F Bonnetain, F Efficace, ...
Health and quality of life outcomes 16 (1), 1-12, 2018
222018
Prevalence projections of chronic diseases and impact of public health intervention
P Joly, C Touraine, A Georget, JF Dartigues, D Commenges, ...
Biometrics 69 (1), 109-117, 2013
202013
Receiver operating characteristic curve estimation for time to event with semicompeting risks and interval censoring
H Jacqmin-Gadda, P Blanche, E Chary, C Touraine, JF Dartigues
Statistical methods in medical research 25 (6), 2750-2766, 2016
102016
Modèles illness-death pour données censurées par intervalle: application à l'étude de la démence
C Touraine
Bordeaux 2, 2013
82013
ADL disability and death in dementia in a French population-based cohort: new insights with an illness-death model
F Delva, C Touraine, P Joly, A Edjolo, H Amieva, C Berr, O Rouaud, ...
Alzheimer's & Dementia 12 (8), 909-916, 2016
72016
SmoothHazard: Fitting illness-death model for interval-censored data
C Touraine, P Joly, TA Gerds
R package version 1.2 3, 2014
62014
Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review
E Charton, B Cuer, F Cottone, F Efficace, C Touraine, Z Hamidou, F Fiteni, ...
Quality of Life Research 29 (4), 867-878, 2020
42020
More accurate cancer-related excess mortality through correcting background mortality for extra variables
C Touraine, N Grafféo, R Giorgi, CENSUR working survival group
Statistical methods in medical research 29 (1), 122-136, 2020
42020
A new score to predict the resectability of pancreatic adenocarcinoma: the BACAP score
C Maulat, C Canivet, C Touraine, S Gourgou, B Napoleon, L Palazzo, ...
Cancers 12 (4), 783, 2020
32020
Kinetics of HE4 and CA125 markers in metastatic ovarian cancer: The META4 study.
PJ Lamy, C Touraine, C Mollevi, S Roques, C Viglianti, F Montels, ...
Journal of Clinical Oncology 35 (15_suppl), e17059-e17059, 2017
22017
Impact d’un programme d’activité physique et de conseil diététique sur la qualité de vie relative à la santé de femmes atteintes de cancer du sein non métastatique sous …
C Touraine, W Jacot, S Gourgou, M Carayol, G Ninot, P Senesse, ...
Revue d’Épidémiologie et de Santé Publique 66, S174, 2018
12018
Méthodes de détermination de la différence minimale cliniquement importante pour les questionnaires de qualité de vie relative à la santé en cancérologie
A Anota, C Touraine, A Ousmen, N Deliu, F Efficace, F Bonnetain, ...
Revue d'Épidémiologie et de Santé Publique 65, S66, 2017
12017
Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results
C Bascoul-Mollevi, A Barbieri, C Bourgier, T Conroy, B Chauffert, ...
Quality of Life Research 30 (1), 91-103, 2021
2021
Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial …
B Cuer, C Mollevi, A Anota, E Charton, B Juzyna, T Conroy, C Touraine
BMC medical research methodology 20 (1), 1-13, 2020
2020
GUIP1: a R package for dose escalation strategies in phase I cancer clinical trials
D Dinart, J Fraisse, D Tosi, A Mauguen, C Touraine, S Gourgou, ...
BMC medical informatics and decision making 20 (1), 1-9, 2020
2020
Modèle conjoint versus modèle linéaire mixte pour l’analyse de données de qualité de vie dont le recueil est interrompu par la survenue d’un évènement clinique en oncologie
C Touraine, B Cuer, T Conroy, B Juzyna, S Gourgou, C Mollevi
Revue d'Épidémiologie et de Santé Publique 68, S131, 2020
2020
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20